GlassScriptPhysician profile
Daniel S Wyzan
NPI 1598781643
$100,265.99
in general payments reported to CMS, 2019-2025
34 companies · $962 in 2025
The $962 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38K · 2020: $21K · 2021: $15K · 2022: $8,841 · 2023: $14K · 2024: $919 · 2025: $962.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Food and Beverage: $3,369.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $13,000.00 |
| Food and Beverage | $3,368.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $91,583.06 | 2019-2025 | Nucala, Arexvy, Trelegy Ellipta |
| Pulmonx Corporation | $2,181.64 | 2019-2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Astrazeneca Pharmaceuticals LP | $2,164.27 | 2019-2025 | Fasenra, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,328.73 | 2019-2025 | Ofev |
| Intuitive Surgical, INC. | $813.27 | 2020-2024 | Da Vinci Surgical System |
| Actelion Pharmaceuticals US, INC. | $266.65 | 2019-2025 | Uptravi, Opsynvi, Opsumit |
| Genentech USA, INC. | $241.47 | 2019 | |
| Viiv Healthcare Company | $225.00 | 2019 | |
| Ambu INC. | $133.42 | 2023-2025 | |
| Inspire Medical Systems, INC. | $127.50 | 2023 | Inspire |
| Vapotherm INC | $122.83 | 2019 | |
| Merck Sharp & Dohme LLC | $122.40 | 2024 | Winrevair |
| Edwards Lifesciences Corporation | $106.40 | 2022 | |
| United Therapeutics Corporation | $97.04 | 2019 | |
| Veran Medical Technologies, INC. | $85.53 | 2019 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $76.86 | 2019 | |
| Genzyme Corporation | $72.34 | 2019-2025 | |
| Philips North America LLC | $68.79 | 2019 | |
| Insmed, INC. | $63.87 | 2019-2025 | Arikayce, Brinsupri |
| Gilead Sciences, INC. | $54.54 | 2019 | |
| Grifols USA, LLC | $50.79 | 2019 | |
| Pfizer INC. | $42.21 | 2019 | |
| Mallinckrodt Enterprises LLC | $31.94 | 2019 | |
| Sunovion Pharmaceuticals INC. | $29.81 | 2019 | |
| Mylan Specialty L.P. | $24.50 | 2019 | |
| Electromed, INC. | $21.28 | 2019 | |
| Shire North American Group INC | $21.11 | 2019 | |
| Jazz Pharmaceuticals INC. | $18.06 | 2019 | |
| Sanofi-Aventis U.S. LLC | $17.01 | 2019 | |
| Olympus America INC. | $17.00 | 2025 | Spiration Valve System |
| E.R. Squibb & Sons, L.L.C. | $15.93 | 2019 | |
| Allergan, INC. | $15.26 | 2019 | |
| Novartis Pharmaceuticals Corporation | $14.57 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $10.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Wyzan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.